Nutritears® for Dry Eye Syndrome

"Indeed, there is evidence hosted on clinicaltrials.gov that confirms the active recruitment of participants for this medical study which was initially shared on August 15th 2022. Currently 124 volunteers are being sought from 3 separate sites with it's latest update occurring September 8th 2022."

"The primary monitored outcome in this study is the Ocular Surface Disease Index (OSDI). Secondary objectives analysed include corneal and conjunctival staining, MMP-9 levels, and tear osmolarity. Corneal and conjunctival staining will be measured using a modified Oxford score from 0 to 5; InflammaDry MMP-9 kits are used for qualitative determination of MMP-9 presence; Tear osmolarity refers to measurements of osmotically active particles which should not exceed 300 milliosmole/L. Measurements will occur at Baseline, Day 14,"

"According to the inclusion parameters spelled out in this clinical trial, potential participants must fall between 18 and 65 years of age."

"Correct. The details on clinicaltrials.gov suggest that this trial is still recruiting participants, with the initial posting dated August 15th 2022 and a recent update to the information occurring on September 8th 2022."

"To join this medical trial, patients must have a diagnosis of dry eye and be aged between 18-65. In total, the research team is looking for 124 participants."